Literature DB >> 25075604

Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer.

Toshifumi Yamaoka1, Chie Doi1, Akinori Yokomi1, Atsushi Tanemura1, Hiroyuki Murota1, Mamori Tani1, Hiroko Saruban2, Yasuhito Hamaguchi3, Manabu Fujimoto3, Ichiro Katayama1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25075604     DOI： 10.1684/ejd.2014.2381

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  3 in total

1.  Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy.

Authors:  Hidenori Ichiyasu; Yasumiko Sakamoto; Chieko Yoshida; Kazuhiko Sakamoto; Ryosuke Fujita; Go Nakayama; Hiroko Okabayashi; Sho Saeki; Shinichiro Okamoto; Hirotsugu Kohrogi
Journal:  Respir Med Case Rep       Date:  2016-12-02

2.  The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level.

Authors:  Takeshi Osawa; Kozo Morimoto; Yuka Sasaki; Shuichi Matsuda; Kazunari Yamana; Ryozo Yano; Takashi Uchiyama; Hajime Goto
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

3.  Treatment of gastric cancer with dermatomyositis as the initial symptom: Two case reports and review of literature.

Authors:  Xiang-Fei Sun; Xiao-Dong Gao; Kun-Tang Shen
Journal:  World J Clin Cases       Date:  2022-09-26       Impact factor: 1.534
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.